Home/Filings/4/0001161697-23-000221
4//SEC Filing

KATZAROFF JAMES C 4

Accession 0001161697-23-000221

CIK 0001502152other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 8:47 PM ET

Size

9.5 KB

Accession

0001161697-23-000221

Insider Transaction Report

Form 4
Period: 2021-05-12
KATZAROFF JAMES C
Executive officer
Transactions
  • Award

    Options

    2021-05-12+30,000,00030,000,000 total
    Exercise: $0.03From: 2021-05-12Exp: 2023-05-12Common stock (30,000,000 underlying)
  • Other

    Common stock

    2023-04-03$0.01/sh+70,422,535$500,00080,422,535 total
  • Award

    Options

    2023-02-24+35,000,00065,000,000 total
    Exercise: $0.01From: 2023-08-24Exp: 2028-02-24Common stock (35,000,000 underlying)
Footnotes (3)
  • [F1]Shares acquired pursuant to conversion of debt of $50,000.
  • [F2]Options vest 50% when granted and balance ratably on a daily basis during the 24 month period commencing on date of grant.
  • [F3]Vested Options are exercisable 6 months after date of grant and thereafter until 5 years after the date of grant.

Issuer

GlobeStar Therapeutics Corp

CIK 0001502152

Entity typeother

Related Parties

1
  • filerCIK 0001286868

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 8:47 PM ET
Size
9.5 KB